Zealand Pharma (Denmark) Buy Hold or Sell Recommendation
| ZEAL Stock | DKK 626.00 15.00 2.45% |
Assuming the 90 days trading horizon and your slightly conservative level of risk, our recommendation regarding Zealand Pharma AS is 'Strong Hold'. Macroaxis provides Zealand Pharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ZEAL positions. The advice algorithm takes into account all of Zealand Pharma's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Zealand Pharma's buy or sell advice are summarized below:
Real Value 444.46 | Hype Value 626 | Market Value 626 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Zealand Pharma AS given historical horizon and risk tolerance towards Zealand Pharma. When Macroaxis issues a 'buy' or 'sell' recommendation for Zealand Pharma AS, the advice is generated through an automated system that utilizes algorithms and statistical models.
Zealand |
Execute Zealand Pharma Buy or Sell Advice
The Zealand recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Zealand Pharma AS. Macroaxis does not own or have any residual interests in Zealand Pharma AS or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Zealand Pharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | OK | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Zealand Pharma Trading Alerts and Improvement Suggestions
| Zealand Pharma AS is way too risky over 90 days horizon | |
| Zealand Pharma AS appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 292.57 M. Net Loss for the year was (1.02 B) with profit before overhead, payroll, taxes, and interest of 173.75 M. | |
| Zealand Pharma AS has accumulated about 1.28 B in cash with (1.21 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 29.66. | |
| Roughly 56.0% of the company outstanding shares are owned by institutional investors |
Zealand Pharma Returns Distribution Density
The distribution of Zealand Pharma's historical returns is an attempt to chart the uncertainty of Zealand Pharma's future price movements. The chart of the probability distribution of Zealand Pharma daily returns describes the distribution of returns around its average expected value. We use Zealand Pharma AS price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Zealand Pharma returns is essential to provide solid investment advice for Zealand Pharma.
| Mean Return | 0.64 | Value At Risk | -4.39 | Potential Upside | 5.07 | Standard Deviation | 5.18 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Zealand Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Zealand Pharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Zealand Pharma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Zealand Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Zealand stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 0.60 | |
β | Beta against NYSE Composite | 0.43 | |
σ | Overall volatility | 5.37 | |
Ir | Information ratio | 0.11 |
Zealand Pharma Volatility Alert
Zealand Pharma AS currently demonstrates below-average downside deviation. It has Information Ratio of 0.11 and Jensen Alpha of 0.6. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Zealand Pharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Zealand Pharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Zealand Pharma Fundamentals Vs Peers
Comparing Zealand Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Zealand Pharma's direct or indirect competition across all of the common fundamentals between Zealand Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Zealand Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Zealand Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Zealand Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Zealand Pharma to competition |
| Fundamentals | Zealand Pharma | Peer Average |
| Return On Equity | -1.44 | -0.31 |
| Return On Asset | -0.48 | -0.14 |
| Operating Margin | (3.82) % | (5.51) % |
| Current Valuation | 10.33 B | 16.62 B |
| Shares Outstanding | 51.28 M | 571.82 M |
| Shares Owned By Insiders | 0.07 % | 10.09 % |
| Shares Owned By Institutions | 56.21 % | 39.21 % |
| Price To Earning | 12.66 X | 28.72 X |
| Price To Book | 27.77 X | 9.51 X |
| Price To Sales | 36.73 X | 11.42 X |
| Revenue | 292.57 M | 9.43 B |
| Gross Profit | 173.75 M | 27.38 B |
| EBITDA | (982.6 M) | 3.9 B |
| Net Income | (1.02 B) | 570.98 M |
| Cash And Equivalents | 1.28 B | 2.7 B |
| Cash Per Share | 29.66 X | 5.01 X |
| Total Debt | 647.91 M | 5.32 B |
| Debt To Equity | 0.10 % | 48.70 % |
| Current Ratio | 4.19 X | 2.16 X |
| Book Value Per Share | 7.91 X | 1.93 K |
| Cash Flow From Operations | (1.21 B) | 971.22 M |
| Earnings Per Share | (23.13) X | 3.12 X |
| Price To Earnings To Growth | 0.31 X | 4.89 X |
| Target Price | 243.75 | |
| Number Of Employees | 203 | 18.84 K |
| Beta | 0.95 | -0.15 |
| Market Capitalization | 11.16 B | 19.03 B |
| Total Asset | 2.07 B | 29.47 B |
| Retained Earnings | 154 M | 9.33 B |
| Working Capital | 463 M | 1.48 B |
| Current Asset | 517 M | 9.34 B |
| Current Liabilities | 54 M | 7.9 B |
| Z Score | 10.2 | 8.72 |
Zealand Pharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Zealand . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Zealand Pharma Buy or Sell Advice
When is the right time to buy or sell Zealand Pharma AS? Buying financial instruments such as Zealand Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Zealand Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Healthcare Thematic Idea Now
Healthcare
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Healthcare theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Healthcare Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Zealand Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for Zealand Stock analysis
When running Zealand Pharma's price analysis, check to measure Zealand Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zealand Pharma is operating at the current time. Most of Zealand Pharma's value examination focuses on studying past and present price action to predict the probability of Zealand Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zealand Pharma's price. Additionally, you may evaluate how the addition of Zealand Pharma to your portfolios can decrease your overall portfolio volatility.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |